We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
+15.91%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$419M
AUM Growth
–
Cap. Flow
+$388M
Cap. Flow %
92.62%
Top 10 Hldgs %
98.59%
Holding
14
New
13
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$255M
2
GKOS icon
Glaukos
GKOS
+$34.9M
3
MGNX icon
MacroGenics
MGNX
+$27M
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$19.5M
5
CDTX
Cidara Therapeutics
CDTX
+$14.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$272M 64.82%
+2,021,403
New +$255M
GKOS icon
2
Glaukos
GKOS
$8.8B
$34.9M 8.33%
+1,018,362
New +$34.9M
MGNX icon
3
MacroGenics
MGNX
$240M
$22M 5.24%
+1,074,316
New +$27M
HIND
4
Vyome Holdings
HIND
$14M
– –
0
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$18.6M 4.44%
+53,320
New +$19.5M
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$14.1M 3.36%
+67,841
New +$14.1M
AGTC
7
DELISTED
Applied Genetic Technologies Corporation
AGTC
$13.6M 3.24%
+1,452,216
New +$13.1M
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$7.89M 1.88%
+512,366
New +$6.65M
IVTY
9
DELISTED
Invuity, Inc
IVTY
$6.21M 1.48%
+1,080,272
New +$9.04M
OCRX
10
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.62M 0.62%
+1,248,064
New +$2.91M
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.3B
$2.46M 0.59%
+320,061
New +$2.57M
KALV
12
DELISTED
KalVista Pharmaceuticals
KALV
$2.33M 0.56%
+329,942
New +$2.43M
LITS
13
Lite Strategy Inc
LITS
$32.9M
$836K 0.2%
+29,020
New +$912K
RETA
14
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$285K 0.07%
+13,058
New +$330K

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q4 2016 Portfolio in Review

Q4 2016 is the first quarter with a 13F filing on record for InterWest Venture Management, which disclosed 14 positions worth $419M. Its ten largest holdings account for 99% of the portfolio.

Its largest position is TESARO, Inc.: 2,021,403 shares worth $272M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets.

  • InterWest Venture Management's largest Q4 2016 buy was TESARO, Inc.: 2,021,403 shares worth $272M.
  • InterWest Venture Management's ten largest holdings make up 99% of its $419M portfolio in Q4 2016.
  • InterWest Venture Management disclosed 14 positions in Q4 2016, its first 13F filing on record.

Based on InterWest Venture Management's 13F filing for Q4 2016, filed 10 Feb 2017.